Cargando…

Asciminib for chronic myeloid leukaemia

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722350/
https://www.ncbi.nlm.nih.gov/pubmed/36479334
http://dx.doi.org/10.18773/austprescr.2022.070
_version_ 1784843954453217280
collection PubMed
description
format Online
Article
Text
id pubmed-9722350
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-97223502022-12-06 Asciminib for chronic myeloid leukaemia Aust Prescr New Drugs NPS MedicineWise 2022-10-12 2022-12 /pmc/articles/PMC9722350/ /pubmed/36479334 http://dx.doi.org/10.18773/austprescr.2022.070 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Asciminib for chronic myeloid leukaemia
title Asciminib for chronic myeloid leukaemia
title_full Asciminib for chronic myeloid leukaemia
title_fullStr Asciminib for chronic myeloid leukaemia
title_full_unstemmed Asciminib for chronic myeloid leukaemia
title_short Asciminib for chronic myeloid leukaemia
title_sort asciminib for chronic myeloid leukaemia
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722350/
https://www.ncbi.nlm.nih.gov/pubmed/36479334
http://dx.doi.org/10.18773/austprescr.2022.070